<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="207640">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00385099</url>
  </required_header>
  <id_info>
    <org_study_id>CRI103143</org_study_id>
    <nct_id>NCT00385099</nct_id>
  </id_info>
  <brief_title>Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome</brief_title>
  <official_title>A Phase IIa, Single-centre, Randomised, Placebo-controlled, Double-blind, Three-period Crossover Study Investigating the Effects on Gut Autonomic Responses of Single Administrations of Either 20 mg or 200 mg GW876008, a CRF1 Antagonist, to Adult Patients With Irritable Bowel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if GW876008 in Irritable Bowel Syndrome patients will
      reverse stress-induced hypersensitivity, by looking at thresholds for perception and pain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double-Blind</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in regional rectal mucosal blood flow in response to a cold water pressor test and in response to a listening test.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Thresholds for rectal pain sensitivity</measure>
  </secondary_outcome>
  <enrollment type="Actual">10</enrollment>
  <condition>Irritable Bowel Syndrome (IBS)</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GW876008</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Must have irritable bowel syndrome.

        Exclusion criteria:

          -  Subjects who have been taking any medication for the treatment of irritable bowel
             syndrome within 6 months prior to the start of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials, MD</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>London</city>
        <zip>NW1 2BU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <lastchanged_date>July 22, 2009</lastchanged_date>
  <firstreceived_date>October 4, 2006</firstreceived_date>
  <firstreceived_results_disposition_date>July 22, 2009</firstreceived_results_disposition_date>
  <responsible_party>
    <name_title>Study Director</name_title>
    <organization>GSK</organization>
  </responsible_party>
  <keyword>IBS</keyword>
  <keyword>CRF1</keyword>
  <keyword>stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted -->
</clinical_study>
